NIH-funded research U01 cooperative agreement

Tiered genetic testing and specialist referrals for rare causes of chronic ear, sinus, and lung infections

Official title: Use of Tiered Genetic Sequencing and Specialty Referral for Identifying and Managing Rare Genetic Causes of Chronic Suppurative Respiratory Disease

Funded at Univ of North Carolina Chapel Hill · NIH-11257668 · Data updated 2026-11-12

This project offers stepwise genetic testing and specialist referrals to find rare inherited causes of persistent ear, sinus, and lung infections in children and adults.

More Respiratory Disease research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startJanuary 15, 2024
Project endDecember 31, 2027
Funding year2026
Award (this year)$363,431
NIH project number5U01HL172658-03
Project IDNIH-11257668 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are children and adults with persistent or recurrent otitis media, sinusitis, bronchitis, or bronchiectasis that suggest an underlying genetic cause.

Less likely to help

People whose infections are clearly due to non-genetic causes or who already have a confirmed diagnosis unrelated to PCD or IEI may not benefit.

What this research studies

If I join, clinicians will collect clinical history and start with targeted genetic panels, moving to whole genome sequencing when initial tests are inconclusive. My samples and clinical information would be reviewed by experts in primary ciliary dyskinesia (PCD) and inborn errors of immunity (IEI) across a consortium. If a genetic cause is found, the team will arrange specialty referrals for immune evaluation or airway management and suggest more specific prevention or treatment plans. The program builds on prior consortium work that discovered many PCD genes and aims to shorten the time to an accurate diagnosis.

Why it matters

Potential benefit: A confirmed genetic diagnosis could lead to tailored treatments or preventive strategies that reduce infections and long-term lung damage.

How similar studies have gone: Previous work by the consortium successfully discovered over 50 genes linked to primary ciliary dyskinesia and has shown genetic testing can reveal immune disorders in similar patients.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Olivier, Kenneth N. — Univ of North Carolina Chapel Hill
  • Study coordinator: Olivier, Kenneth N.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.